Médecins pour CT (tomodensitométrie) en Turquie — Page 15

Dr. Cenap Zeybek is a professor and pediatric cardiologist at Uniqacare Clinic in Istanbul. He specializes in complex heart procedures for children. These include heart valve replacements and open heart surgery. Dr. Zeybek earned his medical degree from Hacettepe University. He later completed a fellowship at Siyami Ersek Cardiovascular Training Hospital.

• Performs interventional procedures like radiofrequency ablation and coronary stenting.
• Treats congenital conditions including Tetralogy of Fallot and atrial septal defects.
• Expertise in cardiac valve plastic surgery and aortic aneurysm repair.
• Works at Uniqacare Clinic, which serves 433,000 patients annually.

Areas of Interests

• Breast cancer
• Lung cancer
• Colorectal cancers
• Gynecological and urogenital cancers
• Molecular Oncology

Education:

• Kızıltepe Anatolian High School 2001
• Dicle University Faculty of Medicine 2007
• Istanbul Medeniyet University Göztepe Training and Research Hospital 2014
• Kartal City Hospital 2021
• Associate Professor of Medical Oncology 2023

Experience:

• Liv Hospital Ulus
• Adıyaman University Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital

Research:

• Phase II, Randomized, Open-Label, Multicenter Study to Comparatively Evaluate the Efficacy and Safety of GDC-9545 and Physician-Preferred Endocrine Monotherapy in Previously Treated, Estrogen Receptor Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer Patients, Other ( International), Dr. Murat Ayhan
• Phase III, Randomized, Evaluating the Efficacy and Safety of Palbociclib and Fulvestrant with Gdc-0077 Compared with Placebo in Patients with Pik3ca-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer. Double Blind, Placebo Controlled Study, Other (International), Dr. Murat Ayhan
• Randomized, Multicenter, Phase Ib/III Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Atezolizumab Compared to Intravenous Atezolizumab in Patients with Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Other (International) Dr. Murat Ayhan
• Randomized, Controlled, Multicenter, Open-Label Study Including Observation Follow-Up for PSMA-PET-Negative Patients, Investigating the Efficacy and Safety of Addition of Apalutamide to Radiotherapy and LHRH Agonist in PSMA-PET-Positive High-Risk Hormone-Sensitive Prostate Cancer Patients, Other (International) Dr. Murat Ayhan
• Biomarker Study to Identify Patients with Advanced Stage Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations-42756493BLC0002, Other (International), Dr. Murat Ayhan
• Publications:
• Ayhan M, Turan N, Köstek O, et all. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology? Curr Probl Cancer. 2021 Jun;45(3):100670. doi: 10.1016/j.currproblcancer.2020.100670.
• Ayhan M, Odabas H, Turan N, et all. Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center's experience. J Chemother. 2021 Nov;33(7):499-508. doi: 10.1080/1120009X.2021.1923153.
• Ayhan M, Laçin Ş, Özyükseler DT, et all. Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? J Oncol Pharm Pract. 2021 Sep;27(6):1461-1467. doi: 10.1177/10781552211015762.
• Ayhan M, Abamor E, Coban Kokten S, et al. Value of FDG PET/CT in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. EJMI 2022;6(2):165–175.
• Ayhan M, Terzioglu K. Experience With Rapid Drug Desensitization With Chemotherapeutics; A SingleCentre Retrospective Study. EJMI 2021;5(3):380–387.
• Doğan A, AYHAN M. Survival analysis of patients with triple-negative breast cancer: a single-center experience. Journal of Oncological Sciences, 8(2), 94-99., Doi: 10.37047/jos.2022-89749
• Terzioğlu K, Ayhan M. Comparative Assessment of Platinum Salts and Taxane Group Hypersensitivity Reactions, The Role of Skin Tests in Diagnosis? J Oncol Pharm Pract. 2021 Nov 30:10781552211050084. doi: 10.1177/10781552211050084.
• Tacar SY, Selcukbiricik F, Yilmaz M, Erturk K, Murat Sarici A, Gulturk I, Ayhan M, Tural D. Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study. Melanoma Res. 2021 Oct 1;31(5):449-455. doi: 10.1097/CMR.0000000000000744.
• Özyurt E, Özçelik S, Sürmeli H, Çelik M, Ayhan M, Özçelik M. Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient? J Oncol Pharm Pract. 2022 Mar;28(2):462-465. doi: 10.1177/10781552211038136.
• Dülgar Ö, Öven BB, Atcı MM, Arıkan R, Ay S, Ayhan M, Selvi O, Ozyukseler DT, Bayram E, Özcan E, Yasin Aİ, Gümüş M. Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy? Expert Rev Anticancer Ther. 2022 Jul;22(7):773-780. doi: 10.1080/14737140.2022.2076670.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study. J Cancer Res Clin Oncol. 2022 Jun;148(6):1501-1508. doi: 10.1007/s00432-021-03748-7.
• Volume I, Kucukarda A, Atcı MM, Ayhan M, et all. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Tumori. 2022 Feb;108(1):19-25. doi: 10.1177/03008916211037739.
• Dogan I, Ayhan M, Gurbuz M, et all. The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study. Medicine (Baltimore). 2022 Sep 2;101(35):e30147. doi: 10.1097/MD.0000000000030147.
• Ozcelik M, Oyman A, Cil I, Duzgun O, Ozkan OF, Ayhan M. Cytoreductive Surgery versus Systemic Chemotherapy alone in Isolated Peritoneal Carcinomatosis of Colorectal Origin. J Coll Physicians Surg Pak. 2021 Nov;31(11):1308-1313. doi: 10.29271/jcpsp.2021.11.1308.
• Başoğlu T, Sakin A, Erol C, Ayhan M, et all. Real life experienceof patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study. J Chemother. 2022 May 17:1-8. doi: 10.1080/1120009X.2022.2073159.
• Özdemir Ö, Zengel B, Yildiz Y, Ayhan M, et all. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study. Anticancer Drugs. 2022 Aug 1;33(7):663-670. doi: 10.1097/CAD.0000000000001310.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study). J Cancer Res Clin Oncol. 2022 Sep 1. doi: 10.1007/s00432-022-04252-2.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study. Future Oncol. 2022 Jul;18(23):2573-2582. doi: 10.2217/fon-2022-0083.
• Topcu A, Atci MM, Secmeler S, Besiroglu M, Ayhan M, Ozkan M, Bozkurt O, Urakci Z, Ay S, Geredeli C, Yasin AI, Turk HM. Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer. Future Oncol. 2021 Nov;17(31):4157-4169. doi: 10.2217/fon-2021-0398.
• Bilgin B, Sendur MAN, Yucel S, Ayhan M, et all. Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study. J Cancer Res Clin Oncol. 2021 Jul;147(7):2145-2152. doi: 10.1007/s00432-020-03501-6.
• Atci MM, Akagunduz B, Demir M, Arikan R, Ay S, Ozer M, Ayhan M, Cil I, Demir N, Ozyurt N, Karakaya G, Cevik GT, Onder AH, Selvi O, Sakin A. The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study. J Chemother. 2023 Feb;35(1):19-28. doi: 10.1080/1120009X.2022.2040770.
• Tataroglu Ozyukseler D, Ay S, Turan M, Alkan G, Ayhan M, Surmeli H, et al. The Systemic Inflammation Response Index as a Prognostic Marker in Advanced Pancreatic Cancer. EJMI 2022;6(3):367–373.
• Yıldız F, Ayhan M, Demir H, et all. Comparing the efficacy of cabazitaxel in secondline and third-Line treatment of metastatic castration-resistant prostate cancer: a multi-center experience from Turkey. International Journal of Contemporary Medical Research, 7(9), 112-116.,Doi: 10.21276/ijcmr.2020.7.9.30
• Terzioğlu K, Ayhan M. Distribution of allergens detected on patch tests of patients with allergic contact dermatitis and investigation of their atopic background. Annals of Medical Research, 29(5), 422-426., doi: 10.5455/annalsmedres.2021.07.490
• Arikan R, Atci MM, Ay S, Ayhan M, et all Prognostic significance of mucinous histology in left sided metastatic colorectal cancers with wild type RAS and evaluation of backbone chemotherapy regimens. Oncol Lett. 2023 Apr 5;25(5):208. doi: 10.3892/ol.2023.13795.
• Almuradova E, Yalcin S, Arıkan R, Ayhan M, Demir H, Cevik GT, Karaca M, Petekkaya I, Karabulut B. Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study. Cureus 2023 May 17;15(5):e39119. doi: 10.7759/cureus.39119.
• Topcu A, Besiroglu M, Atci MM, Ayhan M, et all. Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data. EJMI 2023;7(2):153–161. DOI: 10.14744/ejmi.2023.22720
• Book Writing:
• Drug interactions and side effects of targeted agents, Section name: (Small molecule tyrosine kinase inhibitors; ROS-1 targeted therapies (Crizotinib, Seritinib)) (2021)., AYHAN MURAT, Turkish Clinics Journal of Medical Sciences, Editor: Mehmet Aliustaoglu, Publishing number:1, Number of Pages 92, ISBN:978-625-401- 466-6, Turkish
• Approach to gastrointestinal stromal tumors and neuroendocrine tumors, Department name: (Medical approach in primary non-gastrointestinal neuroendocrine tumors) (2020)., AYHAN MURAT, Akademisyen Yayınevi, Editor: Anılır Ender, Number of editions: 1, Number of Pages 382, ISBN: 9786052585719, Turkish
• Internal medicine emergencies, Department name: (Oncological emergencies) (2022)., YILDIRIM SEDAT, AYHAN MURAT, Efe Academic Publishing, Editor: Serdar Olt, Number of editions: 1, Number of Pages 232, ISBN: 978-625-8324-66- 2, Turkish
• Physicians' chemotherapy cancer drug manual 2020, Section name: (Common chemotherapy regimens in clinical practice) (2022)., SÜMBÜL AHMET TANER, ALKAN ALI, AKSOY ASUDE, AYHAN MURAT, et all, Türkiye Klinikleri Journal of Medical Sciences, Editor: EDWAR CHU, VINCENT T. DEVITA, SAADDETIN KILIÇKAP, CEMIL BILIR, SELÇUK SEBER, Number of editions: 1, Number of pages 772, ISBN: 978-625-401-290- 7, Turkish (Book Translation)

Areas of Interests

• General Neurology
• Clinical Neurophysiological examinations (Electromyography, evoked potentials, electroencephalography, polysomnography)
• Peripheral Nervous System Diseases
• Muscle diseases
• Epilepsy
• Headache
• Sleep and sleep disorders
• Migraine botox and botulinum A toxin applications

Education:

• 1980-1985 Atatürk Elementary School
• 1985-1988 Anamur High School
• 1988-1991 Anamur High School
• 1991-1998 Marmara University Faculty of Medicine in English
• 2000- 2004 PTT Education and Research Hospital Neurology Clinic (Medical Specialization Student)
• 2007-2010 Istanbul University Health Sciences Experimental Medicine Research Institute Electroneurophysiology Master's Program
• 2012- Clinical Neurophysiology Sub-branch Specialist

Experiences:

• September 2023-Currently Haliç University Faculty of Medicine, Faculty Member
• January 2023-Currently Hisar Intercontinental Hospital, Department of Neurology
• 2014- August 2023 Bilgi University Health Sciences Vocational School Electroneurophysiology Department, Faculty Member
• 2019- 2022 Ataşehir Private Avicenna Hospital, Neurology Department
• 2009-2018 Fatih Sultan Mehmet Education and Research Hospital Neurophysiology Laboratory (Specialist Doctor)
• 2007-2010 Istanbul University Health Sciences Experimental Medicine Research Institute Electroneurophysiology Master's Program
• 2005-2006 Istanbul University Istanbul Faculty of Medicine Department of Neurology Electrodiagnostics Department EMG Laboratory
• 2000-2004 PTT Education and Research Hospital Neurology Clinic (Specialist Student in Medicine)

Dr. Necdet Demir is an orthopedic surgeon at Biruni University Hospital in Istanbul. He heads the Orthopedics and Traumatology department at the university. Dr. Demir earned first prize for his research on shoulder MRI at a national congress. He treats complex bone injuries, scoliosis, and degenerative joint diseases.

• Specializes in knee and hip replacement using the MAKOplasty robotic system.
• Performs arthroscopic surgery for the knee, shoulder, and ankle joints.
• Provides stem cell therapy for arthritis and knee conditions.
• Expert in limb prosthetics and surgical treatment for valgus deformities.

Dr. Abdullah Ozkardes is a neurologist at Biruni University Hospital in Istanbul. He specializes in the treatment of epilepsy, Parkinson's disease, and multiple sclerosis. Dr. Ozkardes provides stem cell therapy and deep brain stimulation (DBS). He previously served as Chief Physician at Kutahya Air Hospital.

• Specializes in neurodegenerative conditions like Alzheimer's and muscular dystrophy.
• Performs rehabilitation using robotic exoskeleton and anti-gravity treadmill systems.
• Provides diagnostics including video-EEG monitoring and brainstem evoked response audiometry.
• Is a member of the Turkish Medical Association and the DGCA Health Board.

Domaines d'intérêt

• Chirurgie reconstructive urogénitale pédiatrique
• Hypospadias
• Circumcision
• Chirurgie oncologique
• Anomalies congénitales du système urinaire supérieur et inférieur
• Chirurgie du nouveau-né
• Chirurgie abdominale pédiatrique

Formation
 

• 1997 - Université 19 Mayıs
• 1998 - Congrès national de chirurgie pédiatrique, Meilleure étude de recherche
• 2001 - Université Kocaeli
• 2007 - Gouvernement du Kosovo
• 2009 - Université Yeditepe
• 2009 - Congrès d'Arabie Saoudite, Meilleure étude clinique

Expérience
 

• Lycée FMV Işık
• Faculté de médecine de l’Université d’Istanbul Cerrahpaşa
• Université Ondokuz Mayıs
• Hôpital pour enfants Zeynep Kamil
• Faculté de médecine de l’Université Kocaeli
• UT Southwestern Medical Center, urologie pédiatrique, Dallas, USA
• Centre médical de l’Université Ege, urologie pédiatrique
• Université Yeditepe

Le Prof. Dr. Selami Sozubir est l’auteur de 65 publications scientifiques, ayant reçu plus de 11 000 lectures et près de 1 000 citations, ce qui témoigne de sa contribution importante dans le domaine de la chirurgie et de l’urologie pédiatriques.

Dr. Melih Ucer is a neurosurgeon and associate professor at Biruni University Hospital in Istanbul. He served as a visiting scholar at the University of Wisconsin Clinic of Neurosurgery. Dr. Ucer specializes in complex brain and spine surgeries. He treats conditions like spinal stenosis, brain tumors, and cerebral aneurysms.

• Specializes in transnasal tumor resection and deep brain stimulation (DBS) surgery.
• Performs Gamma Knife radiosurgery and stereotaxic procedures for brain conditions.
• Member of the Turkish Neurosurgical Society and EUROSPINE.
• Practices at Biruni University Hospital, a TEMOS-accredited facility in Turkey.

Dr. Didem Tastekin is a medical oncologist at Biruni University Hospital in Istanbul. She specializes in breast and lung cancer treatment, including stage 4 cases. Dr. Tastekin received the TUBITAK Incentive Award for her work in cancer research. She is an active member of both ESMO and ASCO.

• Awarded Best Researcher of the Year at Istanbul University Oncology Institute.
• Treats complex cases at a TEMOS-accredited university hospital.
• Coordinates oncological check-ups and screenings for both men and women.
• Expert in diagnostics including PET-MRI, tumor markers, and organ biopsies.

Dr. Fikret Baskan is a neurosurgeon at Biruni University Hospital in Istanbul. He is a Faculty Member at Biruni University Department of Neurosurgery. Dr. Baskan has focused on pediatric neurosurgery for nearly a decade. He treats complex cases like brain tumors, spinal cord malformations, and hydrocephalus.

• Specializes in surgical treatment for spina bifida and congenital anomalies.
• Performs neuro-oncological surgery, brain tumor removal, and spinal cord reconstructions.
• Member of the Turkish Neurosurgical Society and the Pediatric Neurosurgery Group.
• Practices at a TEMOS-accredited university hospital with 15 operating rooms.

Dr. Ali Hakan Kaya is a hematologist at Biruni University Hospital in Istanbul. He won first prize from the Blood and Bone Marrow Transplantation Association for his research. Dr. Kaya specializes in stem cell transplants and treating complex blood cancers. He works at a TEMOS-accredited university hospital equipped with a dedicated hematology-oncology department.

• Performs allogeneic bone marrow transplants from both related and unrelated donors.
• Treats leukemia, myeloma, and various types of lymphoma using CAR T-cell therapy.
• Is a member of the Turkish Apheresis Society and the Hematologic Oncology Society.
• Received multiple awards for his scientific papers on hematologic immunology and oncology.

Dr. Ayhan Kaya is a neurosurgeon who speaks English. He graduated from the Dicle University Faculty of Medicine in 1991. He completed his neurosurgery specialization in 2003. He provides surgical care using advanced microsurgical techniques.

Expertise: spinal surgery (herniated discs, spinal stenosis, scoliosis, spinal trauma). Brain tumor surgery (microsurgical removal of benign and malignant tumors). Cerebrovascular surgery (aneurysms, AVMs, vascular malformations). Traumatic brain and spine injuries (emergency and reconstructive). Peripheral nerve surgery (entrapments and injuries). He offers patient-centered, safe, and personalized care.

Dr. Didem Melis Oztas is a cardiovascular surgeon at Biruni University Hospital in Istanbul. She specializes in pediatric cardiac surgery and congenital heart defects. Dr. Oztas won a national award for her research on cardiovascular stem cells.

• Performs specialized surgeries for Tetralogy of Fallot and Atrial Septal Defects.
• Treats complex pediatric heart conditions including ventricular septal defects.
• Expert in pediatric valve replacements and plastic surgery for cardiac valves.
• Works at a TEMOS-accredited university hospital with 15 operating rooms.

Éducation

Étudiant de premier cycle, Faculté de médecine de l'Université Cerrahpaşa d'Istanbul, 1975-1983
Neurologie, Université d'Istanbul, Faculté de médecine Cerrahpaşa, 1986-1991

Langues

Français
Anglais

Intérêts médicaux

• Démence
• Maladies vasculaires cérébrales
• Accident vasculaire cérébral
• Oubli
• Changements de comportement
• Paralysies

qqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqq

Éducation

Licence : Faculté de médecine de l'Université d'Ankara 1998-2004

MSc : Faculté de médecine et de radiologie de l'Université d'Ankara 2005-2010

Expérience

Hôpital d'État de Siverek (service obligatoire) 2010 - 2011

Hôpital privé Polatlı Can 2011 - 2012

Hôpital Memorial d'Antalya 2012 - 2016

Hôpital privé Uncalı Meydan 2016 - 2017

Hôpital privé Lokman Hekim Akay 2017 - 2018

Hôpital Memorial d'Ankara 2018 - 2022

Hôpital Medicana Ataşehir 2022 - 2024

Hôpital universitaire de Biruni 2024-présent

Intérêts médicaux

• Radiologie interventionnelle
• Radiologie diagnostique
• Tomographie informatisée
• Échographie-Échographie Doppler
• Imagerie fluoroscopique

Éducation

Faculté de médecine de l'Université Cerrahpaşa d'Istanbul, doctorat en éducation médicale, 2012, Istanbul/Turquie
Faculté de médecine de l'Université d'Istanbul, résidence en radiologie, 2018, Istanbul/Turquie

Expérience

Hôpital d'État de Muş Bulanık, 2018-2020, Muş/Turquie
Centre de santé communautaire Bahçelievler d'Istanbul, 2013, Istanbul/Turquie

Intérêts médicaux

• Radiologie de l'appareil locomoteur
• Radiologie cardiaque
• Radiologie interventionnelle

Éducation

• Licence : Faculté de médecine de l'Université d'Uludağ 1990-1997
• MSc : Département de radiologie de l'Université de Pamukkale 2002-2007

Expérience

• Professeur adjoint (Assistant Professorship): Université d'Okan 2016-2018
• Professeur associé : Université d'Okan 2018-2024
• Date de la chaire : Université d'Okan 2024

Intérêts médicaux

• Radiologie du thorax
• Radiologie de l'abdomen
• Angiographie cardiaque par tomodensitométrie
• Imagerie de la prostate
• Radiologie pédiatrique
• Radiologie du sein

Éducation

Docteur en médecine Faculté de médecine d'Istanbul Université d'Istanbul 1998-2004
Résidence en orthopédie et traumatologie Département d'orthopédie et de traumatologie Université d'Istanbul, Faculté de médecine d'Istanbul 2004-2010
Göobserver Arthroplastie (chirurgie prothétique) Hôpital de chirurgie spécialisée, New York, États-Unis 2010 (mars-mai)
Chargé de recherche en oncologie orthopédique, Mayo Clinic, Rochester MN, États-Unis 2014-2015
Chargé de recherche clinique en oncologie orthopédique, Université de l'Iowa, Iowa, États-Unis, 2020-2021

Expérience

Professeur associé, Université d'Istanbul, Faculté de médecine d'Istanbul, Département d'orthopédie et de traumatologie, 2012-présent

Intérêts médicaux

• Oncologie orthopédique
• Tumeurs osseuses (ostéosarcome, sarcome d'Ewing, tumeur osseuse à cellules géantes, kystes osseux anévrismaux, etc.)
• Tumeurs des tissus mous (histiocytome fibreux malin, liposarcome, sarcome synovial, tumeur desmoïde, lipome, etc.)
• Reconstruction complexe des membres
• Prothèses de hanche, de genou et révisions
• Maladies orthopédiques